Stocks
Funds
Screener
Sectors
Watchlists

Latest ARMISTICE CAPITAL, LLC Stock Portfolio

ARMISTICE CAPITAL, LLC Performance:
2025 Q4: 6.83%YTD: 10.43%2024: -2.17%

Performance for 2025 Q4 is 6.83%, and YTD is 10.43%, and 2024 is -2.17%.

About ARMISTICE CAPITAL, LLC and 13F Hedge Fund Stock Holdings

ARMISTICE CAPITAL, LLC is a hedge fund based in New York, NY. On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, ARMISTICE CAPITAL, LLC reported an equity portfolio of $8.4 Billions as of 31 Dec, 2025.

The top stock holdings of ARMISTICE CAPITAL, LLC are PTCT, MDGL, IMVT. The fund has invested 2.5% of it's portfolio in PTC THERAPEUTICS INC and 1.8% of portfolio in MADRIGAL PHARMACEUTICALS INC.

The fund managers got completely rid off EXACT SCIENCES ORD (EXAS), VERTEX PHARMACEUTICALS ORD (VRTX) and CHURCHILL DOWNS ORD (CHDN) stocks. They significantly reduced their stock positions in GE AEROSPACE (GE), ABERCROMBIE & FITCH CO (ANF) and BELLRING BRANDS INC (BRBR). ARMISTICE CAPITAL, LLC opened new stock positions in KENVUE INC, GSK PLC (GSK) and DEXCOM INC (DXCM). The fund showed a lot of confidence in some stocks as they added substantially to FLUTTER ENTMT PLC, CROCS INC (CROX) and REVELATION BIOSCIENCES INC (REVB).

ARMISTICE CAPITAL, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that ARMISTICE CAPITAL, LLC made a return of 6.83% in the last quarter. In trailing 12 months, it's portfolio return was 10.43%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
kenvue inc68,865,400
gsk plc49,040,000
dexcom inc21,441,000
energizer hldgs inc new20,606,000
harmony biosciences hldgs in18,710,000
live nation entertainment in17,233,700
klarna group plc15,891,200
kalvista pharmaceuticals inc12,920,000

New stocks bought by ARMISTICE CAPITAL, LLC

Additions

Ticker% Inc.
flutter entmt plc3,517
scilex holding co622
crocs inc468
revelation biosciences inc442
nike inc399
e l f beauty inc394
cencora inc298
agios pharmaceuticals inc297

Additions to existing portfolio by ARMISTICE CAPITAL, LLC

Reductions

Ticker% Reduced
ge aerospace-91.77
abercrombie & fitch co-91.47
bellring brands inc-68.55
roblox corp-67.41
ulta beauty inc-66.29
life time group holdings inc-65.96
mongodb inc-56.28
cme group inc-55.64

ARMISTICE CAPITAL, LLC reduced stake in above stock

Sold off

Ticker$ Sold
volitionrx ord-6,367,430
mobix labs cl a ord-3,705,480
exact sciences ord-56,376,700
soligenix ord-821,280
kartoon studios ord-384,155
jasper therapeutics ord-828,240
carnival ord-4,538,320
energous ord-1,201,510

ARMISTICE CAPITAL, LLC got rid off the above stocks

Sector Distribution

ARMISTICE CAPITAL, LLC has about 55.9% of it's holdings in Healthcare sector.

Sector%
Healthcare55.9
Others17
Technology10.8
Consumer Cyclical8.8
Consumer Defensive3.9
Communication Services2.1

Market Cap. Distribution

ARMISTICE CAPITAL, LLC has about 33.4% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP31.3
LARGE-CAP27.5
UNALLOCATED16.8
SMALL-CAP16.2
MEGA-CAP5.9
MICRO-CAP1.9

Stocks belong to which Index?

About 63.9% of the stocks held by ARMISTICE CAPITAL, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200039.8
Others36.1
S&P 50024.1
Top 5 Winners (%)%
alto neuroscience inc
332.3 %
IRWD
ironwood pharmaceuticals inc
156.6 %
NUVB
nuvation bio inc
110.2 %
AGLE
spyre therapeutics inc
78.0 %
AXGN
axogen inc
74.3 %
Top 5 Winners ($)$
TVTX
travere therapeutics inc
75.0 M
IMVT
immunovant inc
53.9 M
PTCT
ptc therapeutics inc
44.3 M
IRWD
ironwood pharmaceuticals inc
33.1 M
MDGL
madrigal pharmaceuticals inc
23.9 M
Top 5 Losers (%)%
ONFO
onfolio holdings inc
-66.0 %
TMCI
treace med concepts inc
-63.4 %
TPL
texas pacific land corporati
-59.6 %
LMFA
lm fdg amer inc
-57.3 %
ARAY
accuray inc
-47.1 %
Top 5 Losers ($)$
TMCI
treace med concepts inc
-27.0 M
AGIO
agios pharmaceuticals inc
-24.5 M
ELF
e l f beauty inc
-22.3 M
PENN
penn entertainment inc
-11.7 M
FIVN
five9 inc
-8.3 M

ARMISTICE CAPITAL, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL, LLC has 357 stocks in it's portfolio. About 15.1% of the portfolio is in top 10 stocks. TMCI proved to be the most loss making stock for the portfolio. TVTX was the most profitable stock for ARMISTICE CAPITAL, LLC last quarter.

Last Reported on: 17 Feb, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions